Abstract:Objective To study cervical carcinoma cell line HCE1 cell in the therapy of chemotherapy regimen of paclitaxel combined with cisplatin treated on.Methods(1)The human cervical carcinoma cell line HCE1 cells were cultured.(2)Essay grouping and measure:HCE1 cells were cultured and treated by paelitaxel with 20 μmol/L,40 μmol/L and 80 μmol/L concentrations for 24 h respectively.Cell viability were measured by MTT assay.At the same time,HCE1 cells were cultured and treated by paelitaxel with 20 μmol/L,40 μmol/L and 80 μmol/L concentration for 24,48 and 72 h,by cisplatin with 20 μg/ml,40 μg/ml and 80 μg/ml concentration for 24,48 and 72 h,by paelitaxel combined with cisplatin for 24,48 and 72 h,the effect of paelitaxel on HCE1 cells were analyzed by MTT assay,respectively.HCE1 cells were cultured and treated by paelitaxel with 20 μmol/L,40 μmol/L and 80 μmol/L concentrations for 24,48,72 h,the apoptotic rate of HCE1 cell were analyzed by flow cytometry after PI staining,respectively.Treated with 20 μmol/L,40 μmol/L and 80 μmol/L paelitaxel,20 μg/ml,40 μg/ml and 80 μg/ml cisplatin,paelitaxel combined with cisplatin for 24,48 and 72 h,the apoptotic rate and cell cycle distribution were analyzed by flow cytometry after PI staining,respectively.Results(1)HCE1cells became round,small,cell shrinkage,membrane blebbing and so on,after exposed to paelitaxel.(2)After treated with paelitaxel with concentration about 20 μmol/L,40 μmol/L,80 μmol/L for 24 h,HCE1 cell inhibition rate discern was(9.5±0.66)%,(17.1±1.51)%,(33.3±1.77)%,after 48 h,HCE1 cell inhibition rate discern was(28.0±2.27)%,(45.2±3.15)%,(66.0±2.95)%,after 72 h,HCE1 cell inhibition rate discern was(39.4±2.81)%,(66.2±7.02)%,(81.5±1.78)%.After treated with cisplatin with concentration about 20 μg/ml,40 μg/ml and 80 μg/ml for 24 h,HCE1 cell inhibition rate discern was(3.6±0.56)%,(6.5±0.98)%,(14.1±2.52)%,after 48 h,HCE1 cell inhibition rate discern was(6.5±0.46)%,(9.9±1.35)%,(20.0±3.05)%,after 72 h,HCE1 cell inhibition rate discern was(14.1±3.05)%,(42.1±3.90)%,(59.4±4.26)%.After treated with 20 μmol/L paelitaxel combined with 20 μg/ml cisplatin,HCE1 cell inhibition rate discern was(30.2±3.34)%,MTT assays showed that paelitaxel inhibited the growth of the cervical carcinoma cells by concentration and time dependent,and synergistic effect appeared when combined with cisplatin.(3)Flow cytometry results demonstrated that the cell cycle was redistributed:the G1-Phase cell fraction was conspicuous increased while the S-Phase cell fraction was significantly decreased after the cells were treated with paelitaxel(P0.05).However,the result was opposite after treated with cisplatin.When treated with both of them,G1-Phase and S-Phase cell fraction were between the values of single agent.For example,after treated with 20 μmol/L paelitaxel for 48 h,the G1-Phase cell fraction and the S-Phase cell fraction were(86.0±3.01)% and(9.1±0.66)%,after treated with 40 μg/ml cisplatin for 48 h,the G1-Phase cell fraction and the S-Phase cell fraction were(2.1±0.26)% and(92.2±6.24)%,after treated with 20 μmol/L paelitaxel combine with 40 μg/ml cisplatin for 48 h,the G1-Phase cell fraction and the S-Phase cell fraction were(13.2±0.78)% and(80.5±2.46)%.(4)Both of paelitaxel and cisplatin could induce apoptosis in cervical carcinoma cells by a time and dose dependent way.The apoptotic index were significantly increased after treated with paelitaxel combined with cisplatin.Conclusions The apoptotic index is significantly increased after treated with paelitaxel combined with cisplatin,suggesting that the combination of them could exert synergistic antiproliferative effect on cervical carcinoma cells.

Effect of Liposome Encapsulated Paelitaxel on Cervical Carcinoma Cells in Vitro

The Inhibiting Effect of Combination of Allicin with Paclitaxel on Proliferation of Gastric Cancer Cells and Promotion of Apoptosis

Paclitaxel Liposome: Its in Vitro Killing Effect on Endometrial Carcinoma HEC-1A Cells

Killing Effect of Liposome Encapsulated Paclitaxel on Endometrial Carcinoma Ishikawa Cell Line in Vitro

Experimental Study of Effect of Paclitaxel Combined with Cisplatin on Cervical Carcinoma Cell Line HCE1 Cell

Effects of liposomal paclitaxel and paclitaxel in treatment of non-small-cell lung cancer(64 patients) and breast cancer(62 patients)

Study on Taxol in Inhibiting Human Leukemia Cell Proliferation and Inducing Apoptosis

Preparation of thermosensitive liposomes containing paclitaxel and their anticancer effect

Inhibitory Effects of Paclitaxel on Human Embryonal Rhabdomyosarcoma Cell Line RD

In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.

Study On Inhibitory Effect Of Paclitaxel On Mek And Erk Protein Overexpression And Activation In Different Breast Cancer Cell Lines

Human serum albumin-bound paclitaxel nanoparticle inhibits cervical carcinoma cell proliferation and oxidative damage through CYP3A4 and CYP2C8

Development And Evaluation Of A Novel Tpgs-Mediated Paclitaxel-Loaded Plga-Mpeg Nanoparticle For The Treatment Of Ovarian Cancer

Effects of Paclitaxel on the Proliferative Activity and Surface Ultrastructure of Daudi Cells in Vitro

Experimental studies on paclitaxel - induced apoptosis and growth inhibitory effects in Ewing sarcoma cell line of RD-ES in Vitro

Antiangiogenic Activity of Sterically Stabilized Liposomes Containing Paclitaxel (SSL-PTX): In Vitro and In Vivo

Experimental study on growth inhibition of Gefitinid combined with paclitaxel on esophageal carcinoma cells in vitro and in vivo

Targeted Inhibition of Notch1 Gene Enhances the Killing Effects of Paclitaxel on Triple Negative Breast Cancer Cells.

Paclitaxel Induces Apoptosis in Human Gastric Carcinoma Cells

Preparation and Evaluation of Polyethylene Glycol Conjugated Polyethylene Imine‐Coated Magnetic Nanoparticles for Paclitaxel Delivery to Cervical Cancer Cells

[Effect of Estrogen or Progesterone Combined with Paclitaxel on Human Ovarian Cancer Cell Growth and Drosha Expression].